Dr Anthony Menditto, PHD in Fulton, MO - Medicare Psychologist Provider

Dr Anthony Menditto, PHD is a medicare enrolled "Psychologist" provider in Fulton, Missouri. His current practice location is 600 E 5th St, Fulton, Missouri. You can reach out to his office (for appointments etc.) via phone at (573) 592-2623.

Dr Anthony Menditto is licensed to practice in Missouri (license number 05129) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1376729616.

Contact Information

	Dr Anthony Menditto, PHD
	600 E 5th St, Fulton, MO 65251-1753
	(573) 592-2623
	(573) 592-3001

Healthcare Provider's Profile

Full Name	Dr Anthony Menditto
Gender	Male
Speciality	Psychologist
Location	600 E 5th St, Fulton, Missouri
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1376729616
Provider Enumeration Date: 01/17/2008
Last Update Date: 01/17/2008

Medicare PECOS Information:

PECOS PAC ID: 3375628993
Enrollment ID: I20080306000575

Medical Identifiers

Medical identifiers for Dr Anthony Menditto such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1376729616	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	05129 (Missouri)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Anthony Menditto allows following entities to bill medicare on his behalf.

Entity Name	State Of Missouri
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1164477873 PECOS PAC ID: 1456254226 Enrollment ID: O20040129000481

News Archive

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.

COTI reports positive results from first phase of HIV integrase inhibitor discovery program

Critical Outcome Technologies Inc. today announced positive results from the first phase of its HIV integrase inhibitor discovery program. These results provide novel intellectual property to the Company and further validation of the CHEMSAS® drug discovery technology.

Researchers examine proteins on surface of naive CD4+ T cells

The team headed by Dr. Kathrin Suttner, who, together with Prof. Dr. Carsten Schmidt-Weber, heads the airway immunology research group at the Helmholtz Zentrum München and Technische Universität München, concentrated its work on the so-called naive CD4+ T cells.

CRD to conduct review of safety and effectiveness of BMP-2

The Centre for Reviews and Dissemination (CRD) at the University of York is to conduct a major independent review of the effectiveness and safety of bone morphogenetic protein-2 (BMP-2), a product used in spinal surgeries to promote bone growth.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Anthony Menditto is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Anthony Menditto, PHD 600 E 5th St, Fulton, MO 65251-1753 Ph: (573) 592-2623	Dr Anthony Menditto, PHD 600 E 5th St, Fulton, MO 65251-1753 Ph: (573) 592-2623

News Archive

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

COTI reports positive results from first phase of HIV integrase inhibitor discovery program

Researchers examine proteins on surface of naive CD4+ T cells

CRD to conduct review of safety and effectiveness of BMP-2

Psychologist in Fulton, MO

Bryan Zolnikov, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2623 Fax: 573-592-3001
Dr. Jeffrey R Nolting, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2195
Eric Martin, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2623
Dr. Sharon Robbins, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-3365
Kirsten Deming Hunter, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2623
James Bridges, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2623
Megan O'grady, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2613

Dr Anthony Menditto, PHD - Medicare Psychologist in Fulton, MO

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

COTI reports positive results from first phase of HIV integrase inhibitor discovery program

Researchers examine proteins on surface of naive CD4+ T cells

CRD to conduct review of safety and effectiveness of BMP-2

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

COTI reports positive results from first phase of HIV integrase inhibitor discovery program

Researchers examine proteins on surface of naive CD4+ T cells

CRD to conduct review of safety and effectiveness of BMP-2

Psychologist in Fulton, MO